Returning from night shift to day life: Beneficial effects of light on sleep by Thorne, HC et al.
For Review Only
 
 
 
 
 
 
 
Returning from night shift to day life; beneficial effects of 
light on sleep 
 
 
Journal: Sleep and Biological Rhythms 
Manuscript ID: SBR-2010-0021 
Manuscript Type: Full length article 
Keywords: shift work, light, sleep, melatonin 
  
 
 
 
http://mc.manuscriptcentral.com/sbr
Sleep and Biological Rhythms/SBR/manuscript
For Review Only
1 
 
ABSTRACT 
Subjects working a 12h night shift offshore for 2 weeks normally adapt to the night shift and are 
out of synchrony when they return home to day life, with consequent problems of poor sleep. 
The aim of the study was to investigate the effectiveness of timed light treatment to hasten 
circadian adaptation and improve sleep after the night shift. Ten male shift workers worked 
19.00-07.00h (n=4) or 18.00-06.00h (n=6) offshore shift schedules.  They were assessed for the 
last 7 days of a 14 or 21 day night shift offshore and for the following 14 days at home. Either 
timed light treatment/sunglasses or no light treatment/no sunglasses were scheduled in a 
crossover design during days 1-5 after the night shift, theoretically timed to advance the 
circadian system. Subjects wore an Actiwatch-L throughout the study to monitor light and 
activity and completed daily sleep diaries. Actigraphic sleep efficiency after the light/sunglasses 
treatment was significantly improved (days 1-5) 86.7 ± 5.8% (light treatment) compared to the 
no light treatment leg 79.4 ± 10.3% (mean ± SD) P < 0.05. Subjective and objective sleep 
duration (days 6-14) was significantly improved in the light treatment leg; actigraphic sleep 
duration was longer after light treatment (6.75 ± 0.50h) compared to 5.76 ± 0.73h, P < 0.05, 
whilst subjective sleep duration was 8.05 h ± 0.72h compared to 7.32 ± 0.55h, respectively, P < 
0.05. If appropriately timed, light and darkness has beneficial effects on sleep efficiency and 
sleep duration following a night shift.  
 
INTRODUCTION 
Shift work is associated with greater health problems than ‘normal’ day work. 1,2  Night 
shift workers are required to work and eat at the ‘wrong’ phase of their circadian cycle,  resulting 
in complaints of sleepiness, reduced performance and disturbed sleep due to lack of adjustment 
of the circadian timing system. 3-5  Attempts to sleep at inappropriate phases of the circadian 
cycle, for example during the declining phase of melatonin and the rising phase of core body 
temperature, usually result in shorter sleep episodes and more awakenings. 6-8   
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In general, the circadian system adapts either partially or not at all to night shift work. 9,10 
However previous research in unusual circumstances (e.g., working 18.00-06.00 h on offshore 
oil rigs and 20.00-08.00 h in Antarctica) has reported that shift workers can fully adapt to the 
night shift schedule within a week. 11,12  If shift workers fully adapt to a night shift offshore they 
will be out of synchrony with their home environment upon returning home, with consequent 
problems of poor night sleep, reduced daytime alertness and performance and possible digestive 
problems.  Factors such as season, 13 length and timing of the shift, 12,14 early or late initial 
circadian phase, 15 light exposure 9  and sleep/wake patterns (as these indirectly affect light 
exposure), may all affect circadian adaptation.  The use of light treatment at home, appropriately 
timed, may alleviate/reduce the physiological and behavioral problems caused by circadian 
rhythm disturbance experienced following offshore night shift work. 5,16 
Light has been suggested as a counter measure against night work impairment of sleep 
and alertness. 10,17  Intense artificial light can shift the phase of the human circadian timing 
system and has been successfully used to induce phase shifts in circadian rhythms and to 
improve sleep, performance and alertness. 18-21  Bright light as a counter measure for circadian 
desynchrony has also been used in field studies of shift workers, though the number of studies is 
limited. 16, 22-24  Recent research has shown the effectiveness of short wavelength blue light to 
phase shift human circadian rhythms 25,26  and increase alertness. 21,27,28  
Recently Bjorvatn et al. 16  evaluated the effects of bright light and melatonin in offshore 
shift workers working a ‘swing shift’ schedule.  Subjective and objective measures of sleep were 
obtained. Melatonin reduced sleepiness at work during the day shift and increased sleep by 15-20 
mins per day, whilst bright light gave values in between those of melatonin and the placebo, but 
with few statistically significant results. In these studies the effect of melatonin and light on 
circadian phase was not investigated. 
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The aim of this study was to investigate sleep and circadian adaptation in offshore night 
shift workers returning to day life at home after adapting to the night shift offshore.  We 
hypothesized that timed light treatment would improve night sleep at home and would shift the 
circadian rhythm of urinary 6-sulphatoxymelatonin (aMT6s) compared to a “no light treatment” 
condition.   
METHODS 
Pre-study 
Ethical permission was obtained from the University of Surrey Ethics Committee 
(ACE/2002/95SBLS).  Before starting the study, written informed consent was obtained from all 
volunteers.  Subjects had to be working a 2-3 week night shift and were free of any medication 
known to affect the melatonin rhythm (β-blockers, α-blockers, calcium channel blockers, 
antipsychotics, benzodiazepines, antidepressants, barbiturates and antiepileptic drugs). Diurnal 
preference was assessed using the Horne Östberg (HÖ) questionnaire. 29 
Subjects  
Eight men (S1-S8) aged 46 ± 11 years (mean ± SD), body mass index (BMI) 28.1 ± 2.5 
kg/m2, HÖ score 57 ± 8, working a 19.00–07.00 h shift schedule offshore, on an oilrig platform 
in the North Sea at 58°N for 14 or 21 consecutive nights were recruited during the summer 
months (May-August, 2005).  Six men (S9-S14) aged 49 ± 7 years (mean ± SD), BMI 28.4 ± 2.1 
kg/m2, HÖ score 58 ± 4, working a 18.00-06.00 h shift schedule offshore in the North Sea at 
59°N for 14 consecutive nights were recruited during the winter months (October-March, 2006).  
All subjects returned home onshore after finishing their night shift.  
Study design 
Subjects were studied for 21 days, namely the last 7 days offshore of a 2 or 3 week 
19.00-07.00 h night shift or the last 7 days offshore of a 2 week 18.00-06.00 h night shift, and for 
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14 days at home after completion of the night shift.  Subjects completed daily sleep diaries.  
They wore an Actiwatch-L (Cambridge Neurotechnology, Cambridge, UK) for 21 days to record 
light exposure and activity in one-minute epochs.  The subjective sleep parameters recorded 
were sleep onset, defined as the time the subject went to sleep, sleep offset defined as the time 
the subject woke up, sleep latency, number of night awakenings and sleep quality (1 = best ever 
sleep, 9 = worst ever sleep).  In the actigraphy analysis sleep onset, offset, efficiency and 
fragmentation index were analyzed. Light exposure (lux) derived from the Actiwatch-L was 
analyzed in 1 h bins on days 1-5 at home after the night shift to determine the timing of brightest 
daily light exposure period of each individual subject. 
Subjects collected sequential urine samples to assess circadian adaptation to the night 
shift and readaptation after the night shift.  Samples were collected approximately every 4 h 
during waking hours and longer over the sleep period during the last 2 days (48 h) of the night 
shift offshore and the 7 consecutive days after the night shift at home.  
6-sulphatoxymelatonin analysis  
The volume of each sample was measured and a 5 ml aliquot was frozen and transported 
to the University of Surrey for analysis.  6-sulphatoxymelatonin was measured by 
radioimmunoassay, 30 with reagents provided by Stockgrand Ltd, UK.  Interassay coefficients of 
variation at 4.7 ng/ml (n = 14), 14.9 ng/ml (n = 19) and 25.0 ng/ml (n = 15) were 10.0%, 9.9% 
and 9.4%, respectively.  The aMT6s acrophase (individual daily mean peak time for the last 3 
days of night shift, and the 7 consecutive days afterwards) was calculated from cosinor analysis 
of each 24 h period (programme developed and kindly provided by Dr D.S. Minors, University 
of Manchester, UK).   Acrophase values were only accepted if the cosinor fit was significant at 
the 95% level or if the fit was significant at >80% level and the variance (percentage rhythm) 
accounted for by the cosine curve was greater than 50%. Circadian adaptation offshore was 
defined as when the aMT6s acrophase occurred during the day sleep period. Acrophase time is 
given in decimal hours.   
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Light treatment protocol  
The study was a randomized crossover design with two study sessions, one where the 
subject received timed light treatment and wore sunglasses at appropriate times upon returning 
home, and a second session where the sample collection protocol was the same but light 
treatment was not given and sunglasses were not worn.  White polychromatic light (~3000 lux, 
1000 µW/cm2) was administered using a light box (Litebook® Alberta, Canada). Previous studies 
by Gibbs et al. 12 showed that the peak of the aMT6s rhythm of subjects leaving the oil rig after 
working 1 week of night shifts (18.00-06.00 h) was 12.98 ± 0.50 h.  From the findings of this 
previous study, the light treatment protocol was designed as follows: Day 1 was the day the 
subjects returned home onshore, and they were asked to wear specialized light blocking 
sunglasses (Litebook®) from the end of their night shift until 13.00 h on day 1.  On day 2 
subjects wore sunglasses from wake up until 13.00 h and then received light treatment by sitting 
in front of the Litebook® for 1 h, with the device placed at a 45 degree angle, 30 cm in distance 
away from their eyes.  For the following 3 days (days 3-5) the light was scheduled an hour 
earlier each day with subjects wearing sunglasses from wake up until the beginning of the light 
treatment.  This protocol was used for those subjects working the 19.00-07.00 h night shift (n=8).  
Due to the observed variability of results from the 19.00-07.00 h study, it was decided for the 
subsequent study for those working a 18.00-06.00 h shift schedule that the light treatment should 
be individually timed to phase advance the circadian system.  This part of the study was thus not 
randomized as subjects completed the “no light treatment” leg first to allow the aMT6s rhythm 
offshore to be analyzed, and then in the second study leg the light treatment was individually 
timed on the basis of their aMT6s results.  Subjects whose offshore aMT6s acrophase was 
between 11.00-15.00 h followed the protocol as described above (n=7).  One subject had an 
offshore aMT6s acrophase between 15.00-17.00 h and thus started his light treatment on day 2 at 
14.00 h.  
Rate of adaptation 
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The rate of adaptation back to home time between the light and no light treatment legs 
was calculated using the following equation: (aMT6s acrophase on day 5 – mean aMT6s night 
shift acrophase for the last 2 days (days -2 and -1) offshore) / number of days (=5)).   
 
Statistical analysis 
The data from the two shift schedules were grouped together. Statistical analysis (paired 
Student’s t-test) was performed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).  
Statistical significance was set at P < 0.05.  All values are mean ± SD. 
 
RESULTS 
No significant differences were observed in the subjects working the two shift schedules 
(18.00-06.00 h and 19.00-07.00 h) in terms of age, BMI and HÖ score.  In the 19.00-07.00 h 
shift schedule, two subjects (S1 and S2) did not adapt to the night shift, mean (± SD) aMT6s 
acrophases for the last two days offshore were 4.3 ± 0.4 h and 5.3 ± 0.5 h for S1 and S2, 
respectively.  As a result these two subjects were excluded from any further analysis.  Two 
subjects (S3 and S7) only completed one leg of the study and were also excluded from further 
analysis.  Two subjects (S4 and S14) completed sleep diaries and these results are included in the 
analysis but no actigraphy data were obtained and therefore no light exposure analysis could be 
performed.  One subject (S9) collected urine for only one study session; these data were 
therefore not included in the circadian phase analysis.  In total ten subjects were included in the 
sleep analysis, mean age 46.5 ± 7.8 years, BMI 28. ± 2.0 kg/m2 and HÖ score 55 ± 5. 
Prior sleep history 
 Sleep (sleep diaries and actigraphy) prior to the light treatment schedule was assessed for 
7 days offshore (days -7 to -1), as shown in Table 1. Sleep diary sleep duration was 6.79 ± 0.90 
h, whilst actigraphic sleep duration was 5.89 ± 0.65 h.  
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[Table 1 about here] 
 
Circadian phase 
No significant differences (P > 0.05) were observed in the mean aMT6s acrophase during 
the last two days of their night shift offshore between the no light treatment (14.3 ± 2.5 h) and 
light treatment leg (15.0 ± 1.5 h) (paired Student’s t-test).  No significant differences were 
observed in the rate of aMT6s adaptation between the light and no light treatment legs for those 
subjects who had data for both study sessions (n=9).  The mean rate of aMT6s adaptation in the 
no light treatment leg was 2.00 ± 0.45 h/day (mean ± SD) and in the light treatment leg the mean 
rate of aMT6s adaptation was 2.16 ± 0.86 h/day.  In the light treatment session, 2 subjects 
adapted by phase advance, whilst 7 phase delayed whereas in the no light treatment session 8 
subjects adapted by phase delay and 1 subject phase advanced (Table 2).  
Light exposure 
 No significant differences were observed in the mean timing of the brightest light 
exposure (P > 0.05) between the study legs (days 1-5 on returning onshore) (Table 2). In the 
light treatment leg the brightest light exposure period occurred between 10.0-14.0 h (mean 12.9 
± 3.2 h) for all of the subjects and in the no light treatment leg the brightest light exposure period 
occurred between 11.0-16.6 h (mean 13.3 ± 2.7 h) for all of the subjects (Table 2).  However 
significant differences were observed between the light treatment and no light treatment leg (P = 
0.05) in terms of the amount of bright light exposure that occurred during this time period.  In 
the no light treatment leg, mean light exposure was 2252 ± 1631 lux, whilst in the light treatment 
leg mean light exposure was increased to 4644 ± 2602 lux. Light exposure, however, was very 
variable between subjects, with two subjects (S10 and S13) showing little evidence of extra light 
exposure during the light treatment leg.  
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[Table 2 about here] 
 
Sleep 
Sleep analysis after the night shift was separated into days 1-5 (during the light exposure 
treatment) and days 6-14 (which were chosen as the main descriptive analysis for all sleep diary 
and actigraphy data). This allowed a direct comparison between the light and no light treatment 
legs as days 2-5 could have been affected directly by the light treatment.   
Actigraphic sleep 
Individual actigraphy data for the light and no light treatment legs for days 1-5 and days 
6-14 are shown in Tables 3a and b, respectively.  
 
[Table 3a about here] 
 
[Table 3b about here] 
 
 During days 1-5 there was a significant increase (P = 0.05) in the sleep efficiency in the 
light treatment session (86.7 ± 5.8%) compared to the no light treatment session (79.4 ± 10.3%). 
No other statistical differences in actigraphic sleep were observed between the two study 
conditions. During days 6-14 the following differences were observed: sleep onset was 
significantly earlier in the light treatment condition (23.67 ± 0.49 h) compared to the no light 
treatment condition (24.50 ± 0.92 h) (P = 0.02).  Mean actigraphic sleep duration was 
significantly longer (6.75 ± 0.50 h) in the light treatment condition compared to 5.76 ± 0.73 h in 
the no light condition (P = 0.03).  No other statistical differences were observed between the two 
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study conditions although a trend (P = 0.06) to increased sleep efficiency in the light treatment 
leg was observed. 
  Subjective sleep (sleep diaries) 
Individual sleep parameters (mean ± SD, n=10) derived from the daily sleep diaries for 
days 1-5 and for days 6-14 are shown in Tables 4a and b, respectively. 
 
[Table 4a about here] 
 
[Table 4b about here] 
 
During days 1-5 no significant differences in subjective sleep were observed between the 
light and no light conditions.  During days 6-14, however, there was a significant increase in 
sleep duration (8.05 ± 0.72 h) in the light treatment condition compared to 7.32 ± 0.55 h in the 
no light treatment condition (P = 0.03).  No statistical differences were observed in the other 
parameters analyzed (sleep onset, sleep offset, sleep latency, number and duration of night 
awakenings) between the light and no light treatment legs for days 6-14 after the night shift. A 
trend to a reduced number of night awakenings (P = 0.06) during light treatment, however, was 
observed.  
DISCUSSION 
Analysis of the participants’ light exposure revealed that the natural bright light exposure 
was in most subjects (6 out of 8) greater (6105 ± 3444 lux) than the light treatment (3000 lux) 
itself. In the light treatment leg, on day 1 after the night shift all subjects (n=5) with an available 
aMT6s acrophase received the brightest natural light exposure before their peak of melatonin. In 
the no light treatment leg 3 subjects received their brightest natural light exposure before the 
peak of melatonin on day 1, and 2 subjects received their brightest natural light exposure after 
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the peak of melatonin (3 subjects had an unknown acrophase on day 1; Table 2).  If the subjects 
wore sunglasses as instructed this should have counteracted the delaying natural light exposure, 
however the limited evidence suggests that in fact most subjects in both study legs adapted by 
delay to home time.  To force a phase advance in these circumstances, the avoidance of 
conflicting light (e.g. by wearing sunglasses) is likely to be more important than the light 
treatment itself. 
During the first 5 days after the night shift significant differences were only observed in 
actigraphic sleep efficiency, which was substantially improved by light treatment (79 to 87%).  
During days 6-14 (after the light exposure period) measurements of both subjective and 
actigraphic sleep showed there was a significant improvement in sleep duration in the light 
treatment leg compared to the no light treatment leg. Similar results have been reported by 
Dawson and Campbell 31 who investigated the use of timed light treatment for those working 
night shifts.  Workers who were exposed to a 4 h light pulse averaged 62 minutes more sleep 
measured by polysomnography than the control group who received no light.  Other studies have 
reported different findings; Ross et al. 24 who assessed circadian phase (aMT6s) tested light 
treatment in a field study in subjects who were working night shifts in Antarctica.  They reported 
improvement in sleep latency with timed bright light treatment.  Our study, along with Ross et 
al., 24 attempted to investigate in the field if these beneficial findings on sleep were related to 
circadian phase, which this study failed to demonstrate. 
Lastly Bjorvatn et al. 5 investigated offshore shift workers and reported the effects of 30 
mins of bright light treatment (~10,000 lux) given for 4 days upon returning home after 
completion of the 2 week night shift.  Light exposure was scheduled individually to phase delay 
the circadian system, based on the assumption that the circadian nadir was located 2 h before the 
subject’s habitual time of awakening. Light treatment reduced self-rated sleepiness, though in 
this study circadian phase was not assessed.   
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The shift workers studied here slept on average less than a cohort studied by Vorona et al. 
32
 Vorona and colleagues reported that men (n=288) aged 18-91 years with a BMI of 25-29 
kg/m2 and assessed with a sleep questionnaire, slept on average 7.57 h.  In the no light treatment 
leg, subjects’ subjective sleep duration was on average (days 6-14) slightly less (7.32 ± 0.55 h) 
than that studied by Vorona et al. 32  
In our study the improvements in sleep duration during and after light treatment could not 
be attributed to different rates of circadian adaptation as there were no observed differences in 
the rate of adaptation between the light treatment and no light treatment legs. This may be due to 
a number of factors; firstly compliance with the urine sample collection protocol was variable. 
Secondly, natural light exposure during the day could have suppressed melatonin production, 
and therefore calculation of the timing of the aMT6s acrophase would have been affected.  In 
addition, the aMT6s acrophase time on the last days offshore was rather later than we had 
anticipated, and thus the scheduled timing of light treatment may not have been optimal to phase 
advance the circadian system in some cases, for example subjects S11 and S9. Natural light 
exposure received after removing sunglasses and the light treatment and received before the peak 
aMT6s may have been partly responsible for the observed phase delays.  
The findings of this study thus suggest that the effect of light on sleep is not being 
mediated via circadian adaptation. Light can potentially affect sleep in several other ways e.g. 
increased circadian amplitude, increased sleep duration with a change in photoperiod, increased 
daytime activity and consequently better night sleep. 33-36 Recent publications 37,38 demonstrate 
that light acting via melanopsin can directly affect sleep. The Litebox used in this study delivers 
white light in the visible range (400-480 nm) with a peak at 460-480 nm (blue wavelength), and 
the maximal sensitivity of the melanopsin photopigment is known to be in the blue range. 39,40   
Riemersma-van der Lek et al. 33 investigated the effects of bright light and melatonin on 
cognitive and non-cognitive function in elderly residents. Their findings provide evidence for 
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actions of light which are not necessarily related to circadian timing but may influence other 
circadian parameters such as amplitude and hence sleep characteristics.  
Subject motivation may also be very important given that it is virtually impossible to 
blind such light experiments. The subjects recruited in this field study were motivated to try out 
the light treatment hoping that it would reduce their complaints of feeling ‘jet-lagged’ upon 
returning home from night shift.  This may have provoked them to provide more positive 
subjective sleep scores following the bright light treatment.  By contrast, more statistically 
significant differences between the light and no light conditions were observed in the objective 
actigraphic sleep measures than in the subjective sleep diary measures. These findings argue 
against a “placebo” effect of light.  However, as the sleep diary data (sleep onset; sleep offset) 
were used for the actigraphy analysis, this may have added some element of bias towards the 
light treatment study session.   
As with any field study, certain conditions such as natural light exposure or subject 
compliance with study instructions cannot be completely controlled.  There is no control of the 
seasonal and daily changes in the outdoor levels of light; though participating subjects completed 
both study legs in the same season, either summer or winter.  Subjects were asked when 
participating in the light treatment leg to wear the sunglasses provided at certain times; however 
there was no way of checking that this had actually occurred. In addition, clothing covering the 
light monitor cannot be strictly controlled although subjects were instructed to wear the 
activity/light monitor on the outside of the clothing over their sleeves, and to wear it 
continuously apart from when bathing. Despite these limitations light treatment significantly 
improved some sleep parameters.  
It is possible either to phase advance the timing of the circadian system, if light exposure 
is timed on the declining phase of the melatonin rhythm, or to phase delay the circadian system if 
light exposure is timed on the rising phase of the melatonin rhythm. 41-43  Thus if bright light 
exposure occurs at the ‘wrong’ time, this may lengthen the time in which it takes to readapt back 
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to day life, though if subjects are very phase delayed, which was the case for those working the 
19.00-07.00 h shift schedule, it may be better to phase delay the melatonin rhythm rather than 
impose phase advances.   
There was a clear beneficial effect of light treatment on some sleep parameters, however, 
due to the study design using both light and sunglasses it cannot be determined if it was the light 
treatment, the avoidance of light or a combination of the two which was responsible for the 
observed effect.  This ambiguity could only be resolved if two additional study legs were carried 
out: subjects wearing sunglasses only and subjects only being exposed to light. A crossover 
design with four treatment conditions would have made recruitment difficult and would not have 
been possible within the same season due to the long length of each night shift. 
The underlying cause of many of the adverse health effects that are associated with 
working night shifts is thought to be desynchronization of the circadian system with detrimental 
effects on sleep.  Reduction in the length of sleep of between 1-4 hours has been reported to lead 
to increased subjective sleepiness and performance deficits. 44,45  Therefore the poorer sleep 
experienced in the no light treatment leg could have had a detrimental effect on the daytime 
function of this shift work population. 
This study has demonstrated that timed light treatment administered to hasten adaptation 
to day life after working night shift significantly improved both actigraphic and subjective sleep 
duration as well as actigraphic sleep efficiency. 
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Table 1: Sleep diary (n=10) and actigraphy (n=8) data (mean ± SD) for the last 7 days of the first 
leg of the subjects’ night shift, before returning home to day life. 
Sleep parameter Sleep diary Actigraphy  
 
Sleep onset (dec. h) 8.72 ± 1.03 9.06 ± 1.11  
Sleep offset (dec. h) 15.93 ± 1.22 15.89 ± 1.29  
Sleep duration (dec. h) 6.79 ± 0.90 5.89 ± 0.65  
Sleep latency (dec. h) 0.16 ± 0.10 0.22 ± 0.22  
Sleep efficiency (%) N/A 82.7 ± 6.3  
No. of night 
awakenings/day 1.4 ± 0.7 N/A  
Duration of night 
awakenings (dec. h) 0.19 ± 0.13 N/A  
Sleep Quality 4.5 ± 1.0 N/A  
 
N/A – not applicable 
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Table 2: Time and maximum light exposure on days 1-5 onshore (mean ± SD) and aMT6s 
acrophase (day 1) for the light and no light treatment legs. 
 
N/A – not available  
 
*All subjects received light treatment on day 1 at 13.00-14.00 h except S11 who received light 
treatment on day 1 at 14.00-15.00 h. 
 Light treatment   No light treatment 
Subject* 
Time of 
brightest 
light 
exposure 
Light 
exposure 
aMT6s 
acrophase 
 
 
Advance 
or delay 
Time of 
brightest 
light 
exposure 
Light 
exposure (lux) 
aMT6s 
acrophase 
Advance 
or delay 
 (dec.h) (lux) 
day 1 
(dec.h) 
 
(dec.h)  
day 1 
(dec.h)  
S4 14.0 ± 2.5 5701 ± 5692 17.9 
 
Delay 12.8 ± 2.3 4644 ± 4046 
 
N/A Delay 
S5 14.0 ± 2.6 5701 ± 5693 17.2 
 
Delay 13.0 ± 2.2 5771 ± 3875 
 
10.9 Delay 
S6 13.4 ± 2.5 10329 ± 3527 N/A 
 
Delay 16.6 ± 2.5 3091 ± 1376 
 
13.7 Advance 
S8 13.5 ± 2.4 4560 ± 3284 19.4 
 
Advance 12.3 ± 2.2 215 ± 132 
 
15.1 Delay 
S9 12.6 ± 3.0 3783 ± 2354 18.3 
 
Delay 13.5 ± 2.4 678 ± 650 
 
N/A Delay 
S10 10.0 ± 6.2 270 ± 112 N/A 
 
Delay 13.6 ± 4.9 263 ± 101 
 
19.9 Delay 
S11 12.3 ± 1.5 6558 ± 3112 18.1 
 
Advance 11.0 ± 2.6 1105 ± 1237 
 
22.9 Delay 
S13 13.0 ± 5.1 253 ± 40 N/A 
 
Delay N/A N/A 
 
13.1 Delay 
Mean ± 
SD 12.9 ± 3.2 4644 ± 2602 18.2. ± 0.8 
 
13.3 ± 1.7 2252 ± 1631 
 
13.3 ± 2.7  
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Table 3b: Actigraphic sleep parameters for days 6-14 onshore (mean ± SD, n=8) for the no light 
treatment and light treatment legs. 
Sleep parameter No light treatment Light treatment P value 
Sleep onset (dec.h) 24.50 ± 0.92  23.67 ± 0.49  0.02** 
Sleep offset (dec. h) 6.93 ± 0.64 6.86 ± 0.99 0.17 
Sleep duration (dec. h) 5.76 ± 0.73 6.75 ± 0.50 0.03** 
Sleep efficiency (%) 80.6 ± 6.6 84.3 ± 6.3 0.06 
Fragmentation index 36.7 ± 10.7 34.0 ± 10.3 0.13 
Sleep latency (dec. h) 0.34 ± 0.19 0.26 ± 0.19 0.08 
** P < 0.05   
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Table 4a: Subjective sleep parameters for days 1-5 onshore (mean ± SD, n=10) for the no light 
treatment and light treatment legs. 
 
 
 
 
Sleep parameter No light treatment Light treatment P value 
Sleep onset (dec. h) 22.91 ± 0.76  22.92 ± 1.47  0.98 
Sleep offset (dec. h) 6.66 ± 1.64  6.51 ±1.22   0.66 
Sleep duration (dec. h) 7.26 ± 1.50  6.99 ± 0.96  0.27 
Sleep latency (dec. h) 0.13 ± 0.10  0.14 ± 0.11   0.88 
No. of night 
awakenings/day 1.5 ± 0.9 1.3 ± 0.8  0.19 
Duration of night 
awakenings (dec. h) 0.32 ± 0.27  0.31 ± 0.38 0.96 
Sleep quality 5.1 ± 1.2  4.6 ± 1.2  0.09 
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Table 4b: Subjective sleep parameters for days 6-14 onshore (mean ± SD, n=10) for the no light 
treatment and light treatment legs. 
 
Sleep parameter No light treatment Light treatment P-value 
Sleep onset (dec. h) 23.45 ± 0.55 23.15 ± 0.41 0.19 
Sleep offset (dec. h) 7.12 ± 0.72 7.43 ± 1.19  0.22 
Sleep duration (dec. h) 7.32 ± 0.55 8.05 ± 0.72 0.03** 
Sleep latency (dec. h) 0.16 ± 0.10 0.14 ±  0.09 0.27 
No. of night 
awakenings/day 0.60 ± 0.69 0.25 ± 0.31 0.06 
Duration of night 
awakenings (dec. h) 0.19 ± 0.18 0.09 ± 0.06 0.09 
Sleep quality 4.1 ± 1.1 4.6 ± 1.6 0.38 
** P < 0.05   
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